News & Event

2019 Novel Coronavirus (2019-nCoV)
글번호 9 등록일 2020-01-30
등록자 운영자 조회수 1151명
다운로드 2019-nCoV-CDC-23312.png  

IDT has received inquiries from researchers from around the world who are interested in rapidly obtaining assays and developing vaccines targeting the Wuhan coronavirus (2019-nCoV). Supporting these efforts, the CDC and Chinese government have sequenced and submitted the coronavirus genome to the US NCBI GenBank® database [1]. With our world-wide manufacturing capabilities, IDT is uniquely able to provide robust qPCR assays while avoiding contamination issues from synthesis of controls and related gene fragments.

 

VIRUS DETECTION

 

In a swift response to the recent outbreak and rapid spread of 2019-nCoV, IDT is producing CDC assays designed by the US Centers for Disease Control and Prevention (CDC) for identification of virus. The assays are manufactured under ISO:13485 conditions and are available for research use only (RUO). In addition, the CDC has designed an RT-PCR assay and published a protocol for the detection of the 2019-nCoV [2,3]. We anticipate that the FDA will soon issue an Emergency Use Authorization to temporarily expand the use of assays to positively identify the coronavirus [4].


Ordering assays through our dedicated coronavirus channels ensures:

  • * Fast shipping (1–2 business days)
  • * ISO: 13485 standards of production
  • * Most up-to-date CDC assay design
  • * Availability of positive and negative controls
  • * Preferred pricing

VACCINE DEVELOPMENT

 

Advances in gene synthesis mean that subunit vaccines can be developed quickly from one or more antigen-presenting viral genes or peptide sequences, which circumvents the need for scientists to handle live and potentially dangerous pathogens, and eliminates the time needed to clone DNA fragments.

Use IDT double-stranded DNA fragments to create synthetic proteins designed as safe reagents for vaccine research. IDT offers 3 convenient options: linear gBlocks Gene Fragments, eBlocks Gene Fragments, or Custom Genes cloned into vectors. These are available in varying lengths and synthesis scales. Start your order, and we will help you choose the format that best fits your need.


Ordering synthetic gene fragments through our dedicated coronavirus channels ensures:

  • * Priority shipping
  • * Sequence verification
  • * Preferred pricing


 

CDC INFORMATION FOR LABORATORIES


Access the CDC’s latest laboratory guidance for 2019-nCoV RT-PCR assays.


 

REFERENCES

 
  1. 1. (2020) 2019 Novel Coronavirus (2019-nCoV), Wuhan, China. [Online] US Centers for Disease Control and Prevention. [Accessed 28 Jan 2020].
  2. 2. (2020) 2019-Novel coronavirus (2019-nCoV) real-time rRT-PCR panel primers and probes. US Centers for Disease Control and Prevention. [Accessed 28 Jan 2020].
  3. 3. (2020) Real-time RT-PCR panel for detection 2019-novel coronavirus. US Centers for Disease Control and Prevention. [Accessed 28 Jan 2020].
  4. 4. (2020) Emergency use authorization. [Online] US Centers for Disease Control and Prevention. [Accessed 28 Jan 2020].



 


이전글 현장 대응형 Real Time PCR
다음글 [IDT] PACE™ genotyping